Caxton Associates (New York)’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-7,668
Closed -$419K 638
2019
Q4
$419K Buy
7,668
+2,255
+42% +$116K 0.06% 209
2019
Q3
$260K Sell
5,413
-7,061
-57% -$338K 0.05% 288
2019
Q2
$617K Buy
12,474
+3,958
+46% +$212K 0.07% 156
2019
Q1
$501K Sell
8,516
-1,562
-15% -$85.2K 0.07% 149
2018
Q4
$483K Buy
+10,078
New +$532K 0.08% 123
2018
Q2
Sell
-13,472
Closed -$853K 504
2018
Q1
$853K Buy
13,472
+4,281
+47% +$300K 0.04% 211
2017
Q4
$655K Buy
+9,191
New +$617K 0.03% 254
2017
Q2
Sell
-9,100
Closed -$592K 593
2017
Q1
$592K Buy
+9,100
New +$583K ﹤0.01% 210

Other funds holding CDK

Caxton Associates (New York)'s CDK Position: Q1 2020 in Review

Caxton Associates (New York) sold out of CDK Global, Inc. (CDK) in Q1 2020, closing a stake of 7,668 shares — an estimated $419K sold.

Caxton Associates (New York) first reported a position in CDK in Q1 2017 and held it in 8 quarters. The position peaked at $853K in Q1 2018. 467 funds tracked by Wall St. Rank hold CDK as of Q1 2020.

  • Caxton Associates (New York) reported no remaining CDK Global, Inc. position as of Q1 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 7,668 CDK Global, Inc. shares in Q1 2020, an estimated $419K.
  • Caxton Associates (New York) first reported a position in CDK Global, Inc. in Q1 2017 and held it in 8 quarters.
  • Caxton Associates (New York)'s CDK Global, Inc. position peaked at $853K in Q1 2018.
  • 467 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q1 2020.

Based on Caxton Associates (New York)'s 13F filing for Q1 2020, filed 15 May 2020.